243 related articles for article (PubMed ID: 30963028)
1. Identification of an iron-responsive subtype in two children diagnosed with relapsing-remitting multiple sclerosis using whole exome sequencing.
van Rensburg SJ; Peeters AV; van Toorn R; Schoeman J; Moremi KE; van Heerden CJ; Kotze MJ
Mol Genet Metab Rep; 2019 Jun; 19():100465. PubMed ID: 30963028
[TBL] [Abstract][Full Text] [Related]
2. Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part II. Insights from two MS cases.
van Rensburg SJ; Hattingh C; Johannes C; Moremi KE; Peeters AV; van Heerden CJ; Erasmus RT; Zemlin AE; Kemp MC; Jaftha M; Khine AA; Potocnik FCV; Whati L; Engel-Hills P; van Toorn R; Kotze MJ
Metab Brain Dis; 2021 Aug; 36(6):1169-1181. PubMed ID: 33710528
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis-like diagnosis as a complication of previously treated malaria in an iron and vitamin D deficient Nigerian patient.
van Rensburg SJ; van Toorn R; Moremi KE; Peeters AV; Oguniyi A; Kotze MJ
Metab Brain Dis; 2016 Feb; 31(1):197-204. PubMed ID: 26746433
[TBL] [Abstract][Full Text] [Related]
4. Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals.
Hagemeier J; Ramanathan M; Schweser F; Dwyer MG; Lin F; Bergsland N; Weinstock-Guttman B; Zivadinov R
Neuroimage Clin; 2018; 17():530-540. PubMed ID: 29201641
[TBL] [Abstract][Full Text] [Related]
5. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
6. Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole-exome next generation sequencing.
Pytel V; Matías-Guiu JA; Torre-Fuentes L; Montero-Escribano P; Maietta P; Botet J; Álvarez S; Gómez-Pinedo U; Matías-Guiu J
Brain Behav; 2019 Apr; 9(4):e01272. PubMed ID: 30900415
[TBL] [Abstract][Full Text] [Related]
7. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
[TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone.
Foo EC; Russell M; Lily O; Ford HL
Mult Scler Relat Disord; 2020 Sep; 44():102330. PubMed ID: 32599468
[TBL] [Abstract][Full Text] [Related]
9. Rituximab for relapsing-remitting multiple sclerosis.
He D; Guo R; Zhang F; Zhang C; Dong S; Zhou H
Cochrane Database Syst Rev; 2013 Dec; (12):CD009130. PubMed ID: 24310855
[TBL] [Abstract][Full Text] [Related]
10. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis-associated retrovirus, Epstein-Barr virus, and vitamin D status in patients with relapsing remitting multiple sclerosis.
Mostafa A; Jalilvand S; Shoja Z; Nejati A; Shahmahmoodi S; Sahraian MA; Marashi SM
J Med Virol; 2017 Jul; 89(7):1309-1313. PubMed ID: 28165135
[TBL] [Abstract][Full Text] [Related]
12. Whole-Exome Sequencing for Identification of Genetic Variants Involved in Vitamin D Metabolic Pathways in Families With Vitamin D Deficiency in Saudi Arabia.
Alharazy S; Naseer MI; Alissa E; Robertson MD; Lanham-New S; Chaudhary AG
Front Genet; 2021; 12():677780. PubMed ID: 34168679
[TBL] [Abstract][Full Text] [Related]
13. Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio.
Boonsuth R; Samson RS; Tur C; Battiston M; Grussu F; Schneider T; Yoneyama M; Prados F; Ttofalla A; Collorone S; Cortese R; Ciccarelli O; Gandini Wheeler-Kingshott CAM; Yiannakas MC
Front Neurol; 2021; 12():763143. PubMed ID: 34899579
[No Abstract] [Full Text] [Related]
14. Oxidative Stress Related to Iron Metabolism in Relapsing Remitting Multiple Sclerosis Patients With Low Disability.
Siotto M; Filippi MM; Simonelli I; Landi D; Ghazaryan A; Vollaro S; Ventriglia M; Pasqualetti P; Rongioletti MCA; Squitti R; Vernieri F
Front Neurosci; 2019; 13():86. PubMed ID: 30804745
[TBL] [Abstract][Full Text] [Related]
15. Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort.
Tilling K; Lawton M; Robertson N; Tremlett H; Zhu F; Harding K; Oger J; Ben-Shlomo Y
Health Technol Assess; 2016 Oct; 20(81):1-48. PubMed ID: 27817792
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Thouvenot E; Orsini M; Daures JP; Camu W
Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
[TBL] [Abstract][Full Text] [Related]
17. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
[TBL] [Abstract][Full Text] [Related]
18. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
[TBL] [Abstract][Full Text] [Related]
19. Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis.
Horjus J; van Mourik-Banda T; Heerings MAP; Hakobjan M; De Witte W; Heersema DJ; Jansen AJ; Strijbis EMM; de Jong BA; Slettenaar AEJ; Zeinstra EMPE; Hoogervorst ELJ; Franke B; Kruijer W; Jongen PJ; Visser LJ; Poelmans G
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232761
[TBL] [Abstract][Full Text] [Related]
20. Teriflunomide for multiple sclerosis.
He D; Xu Z; Dong S; Zhang H; Zhou H; Wang L; Zhang S
Cochrane Database Syst Rev; 2012 Dec; 12():CD009882. PubMed ID: 23235682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
